Muscle Invasive Bladder Urothelial Carcinoma
Oncology
3 drugs in development·3 companies·1 clinical trial
Drug Pipeline by Phase
Phase 3(2)
Phase 2(1)
| Drug | Company |
|---|---|
| Relatlimab | ENANTA PHARMACEUTICALS INC (ENTA) |
Compare drugs
Frequently asked questions
How many drugs are in development for Muscle Invasive Bladder Urothelial Carcinoma?
BioSniper tracks 3 drugs in development for Muscle Invasive Bladder Urothelial Carcinoma across 3 companies.
How many clinical trials target Muscle Invasive Bladder Urothelial Carcinoma?
There are 1 clinical trial targeting Muscle Invasive Bladder Urothelial Carcinoma tracked by BioSniper.
Deep-dive into Muscle Invasive Bladder Urothelial Carcinoma
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis